Reduced glomerular filtration rate due to loss of nephron mass may be an independent risk factor for atherosclerosis

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1882-1887

  Glodny, Bernhard ^a   Nasseri, Parinaz ^a   Rehder, Peter ^a   Unterholzner, Verena ^a   Plaikner, Michaela ^a   Koppelsttter, Christian ^a   Petersen, Johannes ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

angiolysin; arterial hypertension; calcium scoring; glomerular filtration rate (GFR); medullipin

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AORTIC CALCIUM VOLUME SCORE; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY MASS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; V600 CALCIUM SCORE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INFANT; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASMS; NEPHRECTOMY; NEPHRONS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UROLOGIC DISEASES; YOUNG ADULT;

EID: 79958153949     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq678     Document Type: Article

References (33)

1. Hayslett JP. Effect of age on compensatory renal growth. Kidney Int 1983; 23: 599-602. (Pubitemid 13135656)
2. Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 1979; 59: 137-164. (Pubitemid 9106927)
3. Kaufman JM, Siegel NJ, Hayslett JP. Functional and hemodynamic adaptation to progressive renal ablation. Circ Res 1975; 36: 286-293.
4. Kaufman JM, Hardy R, Hayslett JP. Age-dependent characteristics of compensatory renal growth. Kidney Int 1975; 8: 21-26.
5. Hostetter TH. Hyperfiltration and glomerulosclerosis. Semin Nephrol 2003; 23: 194-199. (Pubitemid 36397101)
6. Kaufman JM, DiMeola HJ, Siegel NJ et al. Compensatory adaptation of structure and function following progressive renal ablation. Kidney Int 1974; 6: 10-17.
7. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12: 1315-1325. (Pubitemid 32472647)
8. Lee GS, Nast CC, Peng SC et al. Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy. Kidney Int 1998; 53: 1389-1398. (Pubitemid 28316903)
9. Olson JL, Hostetter TH, Rennke HG et al. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982; 22: 112-126. (Pubitemid 12061645)
10. Hegde S, Coulthard MG. Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney? Pediatr Nephrol 2009; 24: 439-446.
11. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006; 1: 885-895.
12. Garg AX, Muirhead N, Knoll G et al. Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801-1810. (Pubitemid 44684812)
13. Boudville N, Prasad GV, Knoll G et al. Donor Nephrectomy Outcomes Research (DONOR) Network. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185-196. (Pubitemid 46780564)
14. Foley RN, Ibrahim HN. Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens 2010; 19: 129-133.
15. Lewington S, Clarke R, Qizilbash N et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
16. Glodny B, Helmel B, Trieb T et al. A method for calcium quantification by means of CT coronary angiography using 64-Multidetector CT: very high correlation with Agatston and volume scores. Eur Radiol 2009; 19: 1661-1668.
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
18. Jensky NE, Criqui MH, Wright MC et al. Blood pressure and vascular calcification. Hypertension 2010; 22: 840-841.
19. Budoff MJ, Gul KM. Expert review on coronary calcium. Vasc Health Risk Manag 2008; 4: 315-324. (Pubitemid 351711960)
20. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J 2001; 141: 375-382. (Pubitemid 32200265)
21. Tigerstedt R, Bergmann PG. Niere und Kreislauf. Skand Arch Physiol 1898; 8: 223-271.
22. Paessler D, Heinecke L. Versuche zur Pathologie des Morbus Brightii. Centralbl Allgemein Pathol Anat 1906; 16: 99-117.
23. Glodny B, Glodny DE. John Loesch, discoverer of renovascular hypertension, and Harry Goldblatt: two great pioneers in circulation research. Ann Intern Med 2006; 144: 286-295. (Pubitemid 46768212)
24. Page IH, Helmer OM, Kohlstadt KG et al. Substances in kidneys and muscle eliciting prolonged reduction in blood pressure in human and experimental hypertension. Proc Soc Exp Biol Med 1940; 43: 722-728.
25. Muirhead EE, Stirman JA, Jones F. Renal autoexplantation and protection against renoprival hypertensive cardiovascular disease and hemolysis. J Clin Invest 1960; 39: 266-281.
26. Muirhead EE. The renomedullary system of blood pressure control. Am J Med Sci 1988; 295: 231-233.
27. Glodny B, Pauli GF. The vasodepressor function of the kidney: further characterization of medullipin and a second hormone designated angiolysin. Hypertens Res 2006; 29: 533-544. (Pubitemid 44363470)
28. Folkow B. Incretory renal functions-Tigerstedt, renin and its neglected antagonist medullipin. Acta Physiol (Oxf) 2007; 190: 99-102. (Pubitemid 46776392)
29. Bianchi G, Fox U, Di Francesco GF et al. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974; 47: 435-448.
30. Rettig R, Grisk O. The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies. Hypertension 2005; 46: 463-468. (Pubitemid 41376819)
31. McClellan WM, Chertow GM J. Beyond Framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol 2005; 16: 1539-1541. (Pubitemid 41716460)
32. Wright J, Hutchinson A. Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manage 2009; 5: 713-722.
33. Wang JG, Staessen JA, Franklin SS et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45: 907-913 (Pubitemid 40628936)